Sam Raha named COO at Myriad

ARTICLE | Management Tracks

Plus: Endeavor hires a new CMO, and updates from Jasper, Syantra, Ocuphire, Senisca and more

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst

November 2, 2023 11:28 PM UTC

Genetic testing company Myriad Genetics Inc. (NASDAQ:MYGN) hired Sam Raha as COO, effective Dec.11. Raha was president of the diagnostics and genomics group at Agilent Technologies Inc. (NYSE:A), and previously served as VP of global marketing at Illumina Inc. (NASDAQ:ILMN).

Fibrotic and cancer disease company Endeavor BioMedicines Inc. hired Paul Frohna as CMO. Frohna was CMO and head of R&D at ImCheck Therapeutics S.A.S., before which he was CMO at Bioniz Therapeutics Inc…